Lung Cancer

Web Exclusives | October 25, 2021
Researchers reported that molecular testing in patients with non–small-cell lung cancer aged ≥70 years is performed at the same proportions as in younger patients.
Web Exclusives | October 25, 2021
Analysis of EGFR, KRAS, and PIK3CA gene mutation rates in patients with lung cancer revealed a correlation with clinical characteristics that may have a significant effect on personalized cancer treatment.
Web Exclusives | October 25, 2021
A recently released report indicates that low-dose computed tomography targeted screening for lung cancer confers patient health and public health benefits.
Web Exclusives | October 25, 2021
A large cohort analysis of treatment status, treatment regimen, and outcomes in patients with KRAS-mutated advanced NSCLC revealed valuable information for future clinical trials.
Web Exclusives | September 17, 2021
In recently released study results of the phase 2 CodeBreaK 100 trial, sotorasib demonstrated a response rate across all trial subgroups.
Web Exclusives | September 17, 2021
Lung cancer incidence rates have declined due to a decrease in risk factors and improved screening and treatment.
Web Exclusives | September 17, 2021
Immune checkpoint inhibitors cause rare severe adverse events in patients, but most patients improve with treatment.
Web Exclusives | September 17, 2021
Patients with NSCLC harboring KRAS G12C have distinct imaging patterns from patients with other NSCLC genetic mutations.
Web Exclusives | August 23, 2021
Despite guideline recommendations, a retrospective study found inadequate biomarker testing rates to direct targeted therapy.
Web Exclusives | August 23, 2021
Researchers highlighted promising research into early-stage diagnostics and therapies for NSCLC harboring the KRAS G12C mutation discussed in a review article.
Page 1 of 13
Results 1 - 10 of 128

Subscribe to the Journal of Oncology Navigation & Survivorship®

To sign up for our print publication or e-newsletter, please enter your contact information below.

  • First Name *
    Last Name *
     
     
    Profession or Role
    Primary Specialty or Disease State
    Country
  • Please enter your mailing address.

    Address
     
    Address Line 2
    City
     
    State
    Zip Code